{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:18:18Z","timestamp":1789759098349,"version":"4.0.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12954-016-0100-7","type":"journal-article","created":{"date-parts":[[2016,4,5]],"date-time":"2016-04-05T21:30:45Z","timestamp":1459891845000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Correlates of cocaine use during methadone treatment: implications for screening and clinical management (ANRS Methaville study)"],"prefix":"10.1186","volume":"13","author":[{"name":"The ANRS Methaville study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Lions","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Vilotitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenaelle","family":"Maradan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Marcellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Spire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia M.","family":"Carrieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,5]]},"reference":[{"issue":"9","key":"100_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","volume":"11","author":"M Connock","year":"2007","unstructured":"Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Taylor RJ, et al. Methadone and buprenorphine for the management of opioid dependence: a systematic review and economic evaluation. Health Technol Assess. 2007;11(9):1\u2013171. iii-iv.","journal-title":"Health Technol Assess"},{"issue":"12","key":"100_CR2","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.3109\/10826089809059334","volume":"33","author":"S Magura","year":"1998","unstructured":"Magura S, Kang SY, Nwakeze PC, Demsky S. Temporal patterns of heroin and cocaine use among methadone patients. Subst Use Misuse. 1998;33(12):2441\u201367.","journal-title":"Subst Use Misuse"},{"key":"100_CR3","doi-asserted-by":"crossref","unstructured":"Savant JD, Barry DT, Cutter CJ, Joy MT, Dinh A, Schottenfeld RS et al. Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine\/naloxone treatment. Drug Alcohol Depend. 2012. doi: 10.1016\/j.drugalcdep.2012.06.020 .","DOI":"10.1016\/j.drugalcdep.2012.06.020"},{"issue":"3","key":"100_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0740-5472(03)00130-2","volume":"25","author":"RL Hubbard","year":"2003","unstructured":"Hubbard RL, Craddock SG, Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat. 2003;25(3):125\u201334.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"100_CR5","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1465-3362.2009.00064.x","volume":"28","author":"R Senbanjo","year":"2009","unstructured":"Senbanjo R, Wolff K, Marshall EJ, Strang J. Persistence of heroin use despite methadone treatment: poor coping self-efficacy predicts continued heroin use. Drug Alcohol Rev. 2009;28(6):608\u201315. doi: 10.1111\/j.1465-3362.2009.00064.x .","journal-title":"Drug Alcohol Rev"},{"issue":"5","key":"100_CR6","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1037\/a0016835","volume":"17","author":"GK Tzilos","year":"2009","unstructured":"Tzilos GK, Rhodes GL, Ledgerwood DM, Greenwald MK. Predicting cocaine group treatment outcome in cocaine-abusing methadone patients. Exp Clin Psychopharmacol. 2009;17(5):320\u20135. doi: 10.1037\/a0016835 .","journal-title":"Exp Clin Psychopharmacol"},{"issue":"2","key":"100_CR7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1176\/appi.ajp.2007.06111851","volume":"165","author":"L Dutra","year":"2008","unstructured":"Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2):179\u201387. 10.1176\/appi.ajp.2007.06111851.","journal-title":"Am J Psychiatry"},{"issue":"3","key":"100_CR8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.drugalcdep.2005.09.004","volume":"82","author":"E Peles","year":"2006","unstructured":"Peles E, Schreiber S, Adelson M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend. 2006;82(3):211\u20137.","journal-title":"Drug Alcohol Depend"},{"issue":"1-2","key":"100_CR9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.drugalcdep.2010.05.014","volume":"112","author":"MJ Bravo","year":"2010","unstructured":"Bravo MJ, Llorens N, Barrio G, Brugal MT, Santos S, Sordo L, et al. Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users. Drug Alcohol Depend. 2010;112(1-2):62\u20138. doi: 10.1016\/j.drugalcdep.2010.05.014 .","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"100_CR10","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.3109\/10826081003791932","volume":"45","author":"G Salamina","year":"2010","unstructured":"Salamina G, Diecidue R, Vigna-Taglianti F, Jarre P, Schifano P, Bargagli AM, et al. Effectiveness of therapies for heroin addiction in retaining patients in treatment: results from the VEdeTTE study. Subst Use Misuse. 2010;45(12):2076\u201392. doi: 10.3109\/10826081003791932 .","journal-title":"Subst Use Misuse"},{"issue":"1","key":"100_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1521-0391.2009.00003.x","volume":"19","author":"LE Sullivan","year":"2010","unstructured":"Sullivan LE, Moore BA, O'Connor PG, Barry DT, Chawarski MC, Schottenfeld RS, et al. The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine\/naloxone for the treatment of opioid dependence. Am J Addict. 2010;19(1):53\u20138. doi: 10.1111\/j.1521-0391.2009.00003.x .","journal-title":"Am J Addict"},{"issue":"1","key":"100_CR12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1521-0391.2009.00009.x","volume":"19","author":"EF McCance-Katz","year":"2010","unstructured":"McCance-Katz EF, Jatlow P, Rainey PM. Effect of cocaine use on methadone pharmacokinetics in humans. Am J Addict. 2010;19(1):47\u201352. doi: 10.1111\/j.1521-0391.2009.00009.x .","journal-title":"Am J Addict"},{"issue":"4","key":"100_CR13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAF.0b013e3181ca4b1e","volume":"31","author":"C Albion","year":"2010","unstructured":"Albion C, Shkrum M, Cairns J. Contributing factors to methadone-related deaths in Ontario. Am J Forensic Med Pathol. 2010;31(4):313\u20139. doi: 10.1097\/PAF.0b013e3181ca4b1e .","journal-title":"Am J Forensic Med Pathol"},{"issue":"5","key":"100_CR14","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00414-010-0442-8","volume":"124","author":"PJ Laberke","year":"2010","unstructured":"Laberke PJ, Bartsch C. Trends in methadone-related deaths in Zurich. Int J Legal Med. 2010;124(5):381\u20135. doi: 10.1007\/s00414-010-0442-8 .","journal-title":"Int J Legal Med"},{"issue":"4","key":"100_CR15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s11524-015-9967-y","volume":"92","author":"AJ Visconti","year":"2015","unstructured":"Visconti AJ, Santos GM, Lemos NP, Burke C, Coffin PO. Opioid overdose deaths in the city and county of San Francisco: prevalence, distribution, and disparities. J Urban Health. 2015;92(4):758\u201372. doi: 10.1007\/s11524-015-9967-y .","journal-title":"J Urban Health"},{"key":"100_CR16","author":"SL Proctor","year":"2015","unstructured":"Proctor SL, Copeland AL, Kopak AM, Hoffmann NG, Herschman PL, Polukhina N. Predictors of patient retention in methadone maintenance treatment. Psychol Addict Behav. 2015. doi: 10.1037\/adb0000090 .","journal-title":"Psychol Addict Behav"},{"issue":"5","key":"100_CR17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/10550490600860148","volume":"15","author":"AM Leventhal","year":"2006","unstructured":"Leventhal AM, Mooney ME, DeLaune KA, Schmitz JM. Using addiction severity profiles to differentiate cocaine-dependent patients with and without comorbid major depression. Am J Addict. 2006;15(5):362\u20139. doi: 10.1080\/10550490600860148 .","journal-title":"Am J Addict"},{"issue":"12","key":"100_CR18","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.addbeh.2014.07.009","volume":"39","author":"EM Dunne","year":"2014","unstructured":"Dunne EM, Hearn LE, Rose JJ, Latimer WW. ADHD as a risk factor for early onset and heightened adult problem severity of illicit substance use: an accelerated gateway model. Addict Behav. 2014;39(12):1755\u20138. doi: 10.1016\/j.addbeh.2014.07.009 .","journal-title":"Addict Behav"},{"issue":"4","key":"100_CR19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.4088\/JCP.v69n0407","volume":"69","author":"G Rubio","year":"2008","unstructured":"Rubio G, Manzanares J, Jimenez M, Rodriguez-Jimenez R, Martinez I, Iribarren MM, et al. Use of cocaine by heavy drinkers increases vulnerability to developing alcohol dependence: a 4-year follow-up study. J Clin Psychiatry. 2008;69(4):563\u201370.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"100_CR20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1037\/1064-1297.13.4.293","volume":"13","author":"LA Marsch","year":"2005","unstructured":"Marsch LA, Stephens MA, Mudric T, Strain EC, Bigelow GE, Johnson RE. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence. Exp Clin Psychopharmacol. 2005;13(4):293\u2013302.","journal-title":"Exp Clin Psychopharmacol"},{"issue":"4","key":"100_CR21","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/ADM.0b013e31821b4038","volume":"5","author":"H Delavenne","year":"2011","unstructured":"Delavenne H, Ballon N, Charles-Nicolas A, Garcia FD, Thibaut F, Lacoste J. Attention deficit hyperactivity disorder is associated with a more severe pattern of cocaine consumption in cocaine users from French West Indies. J Addict Med. 2011;5(4):284\u20138. doi: 10.1097\/ADM.0b013e31821b4038 .","journal-title":"J Addict Med"},{"issue":"11","key":"100_CR22","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.addbeh.2006.01.013","volume":"31","author":"DM Herbeck","year":"2006","unstructured":"Herbeck DM, Hser YI, Lu AT, Stark ME, Paredes A. A 12-year follow-up study of psychiatric symptomatology among cocaine-dependent men. Addict Behav. 2006;31(11):1974\u201387. doi: 10.1016\/j.addbeh.2006.01.013 .","journal-title":"Addict Behav"},{"issue":"1","key":"100_CR23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/1471-2458-12-488","volume":"12","author":"P Roux","year":"2012","unstructured":"Roux P, Michel L, Cohen J, Mora M, Morel A, Aubertin JF, et al. Initiation of Methadone in primary care (ANRS-Methaville): a phase III randomized intervention trial. BMC Public Health. 2012;12(1):488. doi: 10.1186\/1471-2458-12-488 .","journal-title":"BMC Public Health"},{"issue":"11","key":"100_CR24","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1097\/01.alc.0000187034.58955.64","volume":"29","author":"P Gache","year":"2005","unstructured":"Gache P, Michaud P, Landry U, Accietto C, Arfaoui S, Wenger O, et al. The Alcohol Use Disorders Identification Test (AUDIT) as a screening tool for excessive drinking in primary care: reliability and validity of a French version. Alcohol Clin Exp Res. 2005;29(11):2001\u20137.","journal-title":"Alcohol Clin Exp Res"},{"key":"100_CR25","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S0767399X00001590","volume":"4","author":"R Fuhrer","year":"1989","unstructured":"Fuhrer R, Rouillon F. La version fran\u00e7aise de l'\u00e9chelle CES-D. Description and translation of the autoevaluation scale (in French). Psychiatrie et Psychobiologie. 1989;4:163\u20136.","journal-title":"Psychiatrie et Psychobiologie"},{"issue":"9","key":"100_CR26","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","volume":"86","author":"TF Heatherton","year":"1991","unstructured":"Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;86(9):1119\u201327.","journal-title":"Br J Addict"},{"issue":"5","key":"100_CR27","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1360-0443.1992.tb02719.x","volume":"87","author":"S Darke","year":"1992","unstructured":"Darke S, Hall W, Wodak A, Heather N, Ward J. Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict. 1992;87(5):733\u201342.","journal-title":"Br J Addict"},{"issue":"4","key":"100_CR28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/1087054714529819","volume":"19","author":"C Daigre","year":"2015","unstructured":"Daigre C, Roncero C, Rodriguez-Cintas L, Ortega L, Lligona A, Fuentes S, et al. Adult ADHD screening in alcohol-dependent patients using the Wender-Utah Rating Scale and the adult ADHD Self-Report Scale. J Atten Disord. 2015;19(4):328\u201334. doi: 10.1177\/1087054714529819 .","journal-title":"J Atten Disord"},{"issue":"3","key":"100_CR29","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.drugalcdep.2013.04.010","volume":"132","author":"G Glind van de","year":"2013","unstructured":"van de Glind G, van den Brink W, Koeter MW, Carpentier PJ, van Emmerik-van Oortmerssen K, Kaye S, et al. Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend. 2013;132(3):587\u201396. doi: 10.1016\/j.drugalcdep.2013.04.010 .","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"100_CR30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/0306624X08319418","volume":"53","author":"AE Perry","year":"2008","unstructured":"Perry AE, Olason DT. A new psychometric instrument assessing vulnerability to risk of suicide and self-harm behaviour in offenders: Suicide Concerns for Offenders in Prison Environment (SCOPE). Int J Offender Ther Comp Criminol. 2008;53(4):385\u2013400. doi: 10.1177\/0306624X08319418 .","journal-title":"Int J Offender Ther Comp Criminol"},{"issue":"3","key":"100_CR31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/00952998709001515","volume":"13","author":"L Handelsman","year":"1987","unstructured":"Handelsman L, Cochrane KJ, Aronson MJ, Ness R, Rubinstein KJ, Kanof PD. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse. 1987;13(3):293\u2013308.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2-3","key":"100_CR32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.drugalcdep.2007.02.007","volume":"89","author":"JD Raffa","year":"2007","unstructured":"Raffa JD, Grebely J, Tossonian H, Wong T, Viljoen M, Khara M, et al. The impact of ongoing illicit drug use on methadone adherence in illicit drug users receiving treatment for HIV in a directly observed therapy program. Drug Alcohol Depend. 2007;89(2-3):306\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"100_CR33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jsat.2011.06.005","volume":"41","author":"J Gryczynski","year":"2011","unstructured":"Gryczynski J, Schwartz RP, Salkever DS, Mitchell SG, Jaffe JH. Patterns in admission delays to outpatient methadone treatment in the United States. J Subst Abuse Treat. 2011;41(4):431\u20139. doi: 10.1016\/j.jsat.2011.06.005 .","journal-title":"J Subst Abuse Treat"},{"issue":"1-3","key":"100_CR34","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.forsciint.2011.01.046","volume":"215","author":"EJ Cone","year":"2012","unstructured":"Cone EJ. Oral fluid results compared to self reports of recent cocaine and heroin use by methadone maintenance patients. Forensic Sci Int. 2012;215(1-3):88\u201391. doi: 10.1016\/j.forsciint.2011.01.046 .","journal-title":"Forensic Sci Int"},{"issue":"1","key":"100_CR35","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1300\/J069v25n01_07","volume":"25","author":"E Peles","year":"2006","unstructured":"Peles E, Kreek MJ, Kellogg S, Adelson M. High methadone dose significantly reduces cocaine use in methadone maintenance treatment (MMT) patients. J Addict Dis. 2006;25(1):43\u201350. doi: 10.1300\/J069v25n01_07 .","journal-title":"J Addict Dis"},{"issue":"4","key":"100_CR36","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jsat.2005.08.002","volume":"29","author":"A Dobler-Mikola","year":"2005","unstructured":"Dobler-Mikola A, Hattenschwiler J, Meili D, Beck T, Boni E, Modestin J. Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment. J Subst Abuse Treat. 2005;29(4):259\u201365. doi: 10.1016\/j.jsat.2005.08.002 .","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"100_CR37","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1521-0391.2013.12047.x","volume":"22","author":"C Daigre","year":"2013","unstructured":"Daigre C, Roncero C, Grau-Lopez L, Martinez-Luna N, Prat G, Valero S, et al. Attention deficit hyperactivity disorder in cocaine-dependent adults: a psychiatric comorbidity analysis. Am J Addict. 2013;22(5):466\u201373. doi: 10.1111\/j.1521-0391.2013.12047.x .","journal-title":"Am J Addict"},{"issue":"3","key":"100_CR38","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1469-7610.2011.02489.x","volume":"53","author":"GH Gudjonsson","year":"2012","unstructured":"Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, Young S. An epidemiological study of ADHD symptoms among young persons and the relationship with cigarette smoking, alcohol consumption and illicit drug use. J Child Psychol Psychiatry. 2012;53(3):304\u201312.","journal-title":"J Child Psychol Psychiatry"},{"issue":"6","key":"100_CR39","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11920-001-0044-8","volume":"3","author":"JJ Wilson","year":"2001","unstructured":"Wilson JJ, Levin FR. Attention deficit hyperactivity disorder (ADHD) and substance use disorders. Curr Psychiatry Rep. 2001;3(6):497\u2013506.","journal-title":"Curr Psychiatry Rep"},{"issue":"33","key":"100_CR40","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.2174\/092986712803988839","volume":"19","author":"L Karila","year":"2012","unstructured":"Karila L, Petit A, Lowenstein W, Reynaud M. Diagnosis and consequences of cocaine addiction. Curr Med Chem. 2012;19(33):5612\u20138.","journal-title":"Curr Med Chem"},{"issue":"3","key":"100_CR41","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.biopsych.2012.07.011","volume":"73","author":"TR Kosten","year":"2013","unstructured":"Kosten TR, Wu G, Huang W, Harding MJ, Hamon SC, Lappalainen J, et al. Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine beta-hydroxylase. Biol Psychiatry. 2013;73(3):219\u201324. doi: 10.1016\/j.biopsych.2012.07.011 .","journal-title":"Biol Psychiatry"},{"issue":"1-2","key":"100_CR42","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.drugalcdep.2012.05.019","volume":"126","author":"KM Carroll","year":"2012","unstructured":"Carroll KM, Nich C, Shi JM, Eagan D, Ball SA. Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: a randomized placebo-controlled trial. Drug Alcohol Depend. 2012;126(1-2):224\u201331. doi: 10.1016\/j.drugalcdep.2012.05.019 .","journal-title":"Drug Alcohol Depend"},{"issue":"2-3","key":"100_CR43","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.drugalcdep.2010.07.022","volume":"113","author":"A Oliveto","year":"2011","unstructured":"Oliveto A, Poling J, Mancino MJ, Feldman Z, Cubells JF, Pruzinsky R, et al. Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug Alcohol Depend. 2011;113(2-3):184\u201391. doi: 10.1016\/j.drugalcdep.2010.07.022 .","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"100_CR44","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/archpsyc.59.9.817","volume":"59","author":"RA Rawson","year":"2002","unstructured":"Rawson RA, Huber A, McCann M, Shoptaw S, Farabee D, Reiber C, et al. A comparison of contingency management and cognitive-behavioral approaches during methadone maintenance treatment for cocaine dependence. Arch Gen Psychiatry. 2002;59(9):817\u201324.","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"100_CR45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1037\/0893-164X.17.1.73","volume":"17","author":"DH Epstein","year":"2003","unstructured":"Epstein DH, Hawkins WE, Covi L, Umbricht A, Preston KL. Cognitive-behavioral therapy plus contingency management for cocaine use: findings during treatment and across 12-month follow-up. Psychol Addict Behav. 2003;17(1):73\u201382.","journal-title":"Psychol Addict Behav"},{"issue":"4","key":"100_CR46","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11845-011-0803-4","volume":"181","author":"C Darker","year":"2012","unstructured":"Darker C, Sweeney B, El Hassan H, Kelly ASOC, Smyth B, et al. Non-attendance at counselling therapy in cocaine-using methadone-maintained patients: lessons learnt from an abandoned randomised controlled trial. Ir J Med Sci. 2012;181(4):483\u20139. doi: 10.1007\/s11845-011-0803-4 .","journal-title":"Ir J Med Sci"},{"issue":"1","key":"100_CR47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2174\/1874473711003010049","volume":"3","author":"JK Penberthy","year":"2010","unstructured":"Penberthy JK, Ait-Daoud N, Vaughan M, Fanning T. Review of treatment for cocaine dependence. Curr Drug Abuse Rev. 2010;3(1):49\u201362.","journal-title":"Curr Drug Abuse Rev"},{"issue":"2","key":"100_CR48","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2466\/pr0.100.2.520-524","volume":"100","author":"A Lopez","year":"2007","unstructured":"Lopez A, Becona E. Depression and cocaine dependence. Psychol Rep. 2007;100(2):520\u20134.","journal-title":"Psychol Rep"},{"issue":"5","key":"100_CR49","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1521-0391.2011.00148.x","volume":"20","author":"E Dakwar","year":"2011","unstructured":"Dakwar E, Nunes EV, Bisaga A, Carpenter KC, Mariani JP, Sullivan MA, et al. A comparison of independent depression and substance-induced depression in cannabis-, cocaine-, and opioid-dependent treatment seekers. Am J Addict. 2011;20(5):441\u20136. doi: 10.1111\/j.1521-0391.2011.00148.x .","journal-title":"Am J Addict"},{"issue":"2","key":"100_CR50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/00952990.2011.644002","volume":"38","author":"M Afshar","year":"2012","unstructured":"Afshar M, Knapp CM, Sarid-Segal O, Devine E, Colaneri LS, Tozier L, et al. The efficacy of mirtazapine in the treatment of cocaine dependence with comorbid depression. Am J Drug Alcohol Abuse. 2012;38(2):181\u20136.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"100_CR51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jsat.2010.11.010","volume":"40","author":"EL Winstanley","year":"2011","unstructured":"Winstanley EL, Bigelow GE, Silverman K, Johnson RE, Strain EC. A randomized controlled trial of fluoxetine in the treatment of cocaine dependence among methadone-maintained patients. J Subst Abuse Treat. 2011;40(3):255\u201364. doi: 10.1016\/j.jsat.2010.11.010 .","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"100_CR52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1360-0443.2011.03552.x","volume":"107","author":"A Oliveto","year":"2012","unstructured":"Oliveto A, Poling J, Mancino MJ, Williams DK, Thostenson J, Pruzinsky R, et al. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Addiction. 2012;107(1):131\u201341.","journal-title":"Addiction"},{"issue":"3","key":"100_CR53","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00952990701313686","volume":"33","author":"FG Moeller","year":"2007","unstructured":"Moeller FG, Schmitz JM, Steinberg JL, Green CM, Reist C, Lai LY, et al. Citalopram combined with behavioral therapy reduces cocaine use: a double-blind, placebo-controlled trial. Am J Drug Alcohol Abuse. 2007;33(3):367\u201378.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"10","key":"100_CR54","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/j.1360-0443.2005.01232.x","volume":"100","author":"EC Donny","year":"2005","unstructured":"Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL. Methadone doses of 100\u00a0mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction. 2005;100(10):1496\u2013509.","journal-title":"Addiction"},{"issue":"4","key":"100_CR55","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1465-3362.2011.00353.x","volume":"31","author":"AJ Bond","year":"2012","unstructured":"Bond AJ, Reed KD, Beavan P, Strang J. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication. Drug Alcohol Rev. 2012;31(4):492\u20138.","journal-title":"Drug Alcohol Rev"},{"issue":"8","key":"100_CR56","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1177\/1087054711425768","volume":"16","author":"JP Chiasson","year":"2012","unstructured":"Chiasson JP, Stavro K, Rizkallah E, Lapierre L, Dussault M, Legault L, et al. Questioning the specificity of ASRS-v1.1 to accurately detect ADHD in substance abusing populations. J Atten Disord. 2012;16(8):661\u20133.","journal-title":"J Atten Disord"},{"issue":"3","key":"100_CR57","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0376-8716(98)00028-3","volume":"51","author":"S Darke","year":"1998","unstructured":"Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998;51(3):253\u201363. discussion 67-8.","journal-title":"Drug Alcohol Depend"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-016-0100-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T06:16:19Z","timestamp":1600409779000},"score":1,"resource":{"primary":{"URL":"http:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-016-0100-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,5]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["100"],"URL":"https:\/\/doi.org\/10.1186\/s12954-016-0100-7","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,5]]},"article-number":"12"}}